Found: 12
Select item for more details and to access through your institution.
Front Cover.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. C1, doi. 10.1111/dom.15371
- By:
- Publication type:
- Article
Efficacy and safety of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, 52‐week clinical trial (EMPA‐ELDERLY)
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 12, p. 3538, doi. 10.1111/dom.15249
- By:
- Publication type:
- Article
Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 1, p. 53, doi. 10.1007/s40261-020-00979-3
- By:
- Publication type:
- Article
Cautionary note on regional consistency evaluation in multiregional clinical trials with binary outcomes.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 3, p. 385, doi. 10.1002/pst.2358
- By:
- Publication type:
- Article
Sample size calculation in clinical trials with two co‐primary endpoints including overdispersed count and continuous outcomes.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 46, doi. 10.1002/pst.2337
- By:
- Publication type:
- Article
Sequential parallel comparison design with two coprimary endpoints.
- Published in:
- Pharmaceutical Statistics, 2020, v. 19, n. 3, p. 243, doi. 10.1002/pst.1987
- By:
- Publication type:
- Article
A simple test for the treatment effect in clinical trials with a sequential parallel comparison design and negative binomial outcomes.
- Published in:
- Pharmaceutical Statistics, 2019, v. 18, n. 2, p. 184, doi. 10.1002/pst.1913
- By:
- Publication type:
- Article
Usefulness of the placebo lead-in design for clinical trials with binary outcomes.
- Published in:
- Clinical Trials, 2023, v. 20, n. 2, p. 145, doi. 10.1177/17407745221140048
- By:
- Publication type:
- Article
Phase 2 randomized placebo‐controlled study of lasmiditan for the acute treatment of migraine in Japanese patients.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 5, p. 755, doi. 10.1111/head.14122
- By:
- Publication type:
- Article
Sequential parallel comparison design for "gold standard" noninferiority trials with a prespecified margin.
- Published in:
- Biometrical Journal, 2019, v. 61, n. 6, p. 1493, doi. 10.1002/bimj.201800394
- By:
- Publication type:
- Article
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ramucirumab or placebo plus erlotinib in EGFR‐mutated, metastatic non‐small‐cell lung cancer: East Asian subset of RELAY.
- Published in:
- Cancer Science, 2020, v. 111, n. 12, p. 4510, doi. 10.1111/cas.14655
- By:
- Publication type:
- Article